Antibe Therapeutics Inc. — Form D
Antibe Therapeutics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-09. The offering totals $55K, of which $55K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-08-09
- Form: D
- Accession: 0001583682-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $55K
- Amount sold: $55K
- Investors: 1
- Date of first sale: 2013-06-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-201070
Issuer
- Name: Antibe Therapeutics Inc.
- CIK: 0001583682
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2009
- Address: 15 PRINCE ARTHUR AVENUE, TORONTO, A6, M5R 1B2
- Phone: 905-570-5103
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jonathan Goodman | Director | Arlington, VA |
| Michael Bumby | Executive Officer | Toronto, A6 |
| David Vaughan | Executive Officer | JUPITER, FL |
| JOHN WALLACE | Executive Officer | TORONTO, A6 |
| Alain Wilson | Executive Officer | Montreal, A8 |
| DANIEL LEGAULT | Director | TORONTO, A6 |
| DANIEL LEGAULT | Executive Officer | TORONTO, A6 |
| YUNG WU | Director | TORONTO, A6 |
| AMAL KHOURI | Director | TORONTO, A6 |
| WALT MACNEE | Director | TORONTO, A6 |
| JOHN WALLACE | Director | TORONTO, A6 |
| RODERICK FLOWER | Director | TORONTO, A6 |
Other filings by this issuer (1)
More